To include your compound in the COVID-19 Resource Center, submit it here.

Replacing the replacements

How cell-based HRT could solve problematic pharmacologic approaches

A Wake Forest team has developed a cell-based hormone replacement therapy that can control the hypothalamic-pituitary-ovarian axis with lower levels of estrogen than standard therapies, and could provide a solution to the side effects of standard HRTs.

The decline in ovarian hormones during menopause leads to osteoporosis, fat accumulation and uterine wall thickening, among other complications, but hormone replacement therapies (HRTs) consisting of estrogen, or estrogen and progesterone, don’t replace all of hormones lost,

Read the full 731 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers